These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18807486)

  • 1. [Fluorescence of age in serum in detecting liver cirrhosis and hepatocellular carcinoma among patients with anti-HCV antibodies].
    Górka J; Zuwała-Jagiełło J; Pazgan-Simon M; Simon K; Warwas M
    Przegl Epidemiol; 2008; 62(2):393-400. PubMed ID: 18807486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis.
    Ulu M; Alacacioglu A; Yuksel E; Pamukk BO; Bozkaya G; Ari A; Yuksel A; Sop G; Alacacioglu I
    Saudi J Gastroenterol; 2015; 21(1):47-50. PubMed ID: 25672239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
    Mondal G; Saroha A; Bose PP; Chatterjee BP
    Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C antibody and cryoglobulins in patients with cirrhosis and hepatocellular carcinoma.
    Rinaldi G; Saccardo F; Petrozzino MR; Bossi E; Manna MR; Monti G
    Clin Exp Rheumatol; 1995; 13 Suppl 13():S161-3. PubMed ID: 8730499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma.
    Moussa YI; Plevris JN; Hayes PC
    Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):159-63. PubMed ID: 10741929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
    Cervello M; Virruso L; Lipani G; Giannitrapani L; Soresi M; Carroccio A; Gambino R; Sanfililippo R; Marasà L; Montalto G
    J Cancer Res Clin Oncol; 2000 Jun; 126(6):345-51. PubMed ID: 10870645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HBs Ag and antibodies to hepatitis C virus in complicated chronic liver disease in Gabon. A case control study].
    Perret JL; Moussavou-Kombila JB; Delaporte E; Pemba LF; Boguikouma JB; Matton T; Larouze B
    Gastroenterol Clin Biol; 2002 Feb; 26(2):131-5. PubMed ID: 11938063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
    Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
    Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoproteomic discovery of serological biomarker candidates for HCV/HBV infection-associated liver fibrosis and hepatocellular carcinoma.
    Kaji H; Ocho M; Togayachi A; Kuno A; Sogabe M; Ohkura T; Nozaki H; Angata T; Chiba Y; Ozaki H; Hirabayashi J; Tanaka Y; Mizokami M; Ikehara Y; Narimatsu H
    J Proteome Res; 2013 Jun; 12(6):2630-40. PubMed ID: 23586699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
    Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
    Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S; Shiota G; Kawasaki H
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenium levels in patients with hepatitis C virus-related chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma: a pilot study.
    Bettinger D; Schultheiss M; Hennecke N; Panther E; Knüppel E; Blum HE; Thimme R; Spangenberg HC
    Hepatology; 2013 Jun; 57(6):2543-4. PubMed ID: 23172787
    [No Abstract]   [Full Text] [Related]  

  • 16. [HBV and HCV coinfections in children--own investigations].
    Pawłowska M; Halota W
    Przegl Epidemiol; 2003; 57(3):459-64. PubMed ID: 14682164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot clinical trial of the use of alpha-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosis.
    Takagi H; Kakizaki S; Sohara N; Sato K; Tsukioka G; Tago Y; Konaka K; Kabeya K; Kaneko M; Takayama H; Hashimoto Y; Yamada T; Takahashi H; Shimojo H; Nagamine T; Mori M
    Int J Vitam Nutr Res; 2003 Nov; 73(6):411-5. PubMed ID: 14743544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistin and Insulin Resistance: A Link Between Inflammation and Hepatocarcinogenesis.
    Elsayed EY; Mosalam NA; Mohamed NR
    Asian Pac J Cancer Prev; 2015; 16(16):7139-42. PubMed ID: 26514502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.
    Nada O; Abdel-Hamid M; Ismail A; El Shabrawy L; Sidhom KF; El Badawy NM; Ghazal FA; El Daly M; El Kafrawy S; Esmat G; Loffredo CA
    J Clin Virol; 2005 Oct; 34(2):140-6. PubMed ID: 16157266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.